REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
14/07/2025
Voltar para busca
Dado oficial do USPTO
ALYVANT
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Snapshot rápido
ST13
US500000079263445Classe
9, 35, 41, 42, 44
Pedido
79263445
Registro
6098335
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
31
Atualização mais recente
15/07/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
9, 35, 41, 42, 44
Data de depósito
12/10/2018
Data de registro
14/07/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
14/07/2020
Última transação
15/07/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
27
Localização do titular
CH
Examinador
RHIM, ANDREW
Unidade examinadora
L10
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the wording ''ALYVANT'' to the right of an interconnected circle design and additional circle design.
Titulares e representantes
Titulares
Roivant Sciences GmbH
Representantes
Allison Strickland Ricketts FROSS ZELNICK LEHRMAN & ZISSU, P.C.
Classificação técnica
Classes Nice
Classe 9Classe 35Classe 41Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Downloadable computer software for providinganalyzing and generating reports; downloadable computer software for data processing; downloadable software and downloadable computer programs for the capturecollectionconversionanalysiscommunicationprocessingreceivingrecordingstorage and/or transmission of dataimages and information; downloadable software and downloadable computer programs for the conversionanalysisprocessingstorage and transmission of artificial intelligence; downloadable computer software for database integration; downloadable computer software for creating searchable databases of information and data; downloadable software for analytics in the fields of public healthhealthcarepharmaceutical commercializationbiomedical research and development and for analyzing clinical trial data; downloadable computer software for use in management of databases featuring pharmaceutical and medical information; downloadable computer software for management of medical practices and research; downloadable computer search engine software for obtaining and providing updated scientificmedical and clinical informationfor obtaining and providing news of general interest related to disease awareness or pharmaceutical products; downloadable computer software for accessing data and information related to healthcare services and patient medical informationfor controlling and managing data and information related to healthcare services and patient medical information; downloadable computer software for measuringmonitoringprocessing and tracking healthwellness and medical information
Classe 35
Advertising services related to pharmaceutical products; business management; business administration; business research and information services; market research and provision of information regarding market research; data processing services; analysis of business data; business data and statistical analysisdocumentation being compilation of statistics and professional business consultancy services regarding statistics for biomedical researchrelated to pharmaceutical commercializationhealthcare institutions and healthcare professionalsbased on artificial intelligence and machine learning; business data analysis and statistical analysis of healthcare databiomedical research and clinical trial data for business purposes to include pharmaceutical commercialization; systematization and compilation of data in computer databases; analyzing and compiling of business data and analysis of business management for medicalpurposespublic health and healthcare purposes; business researchmarket testing being market research and statistical analysis services for business purposes in the fields of public healthhealthcare and biomedicinepharmaceutical commercialization and productsfor clinical trials; business advisory servicesconsultancy and information; advertisingmarketing and sales promotion services for the pharmaceutical and medical products of others; providing business intelligence services in the fields of pharmaceuticalspublic health and healthcare; providing an on-line database providing business intelligence in the fields of pharmaceuticalspublic health and healthcare
Classe 41
Educational servicesarrangingconducting and organizing classesseminarsconferencessymposiums and training workshops in the field of healthcare and pharmaceuticals to promote the exchange of information and resources within the scientific research and medical communities to achieve advances in the fields of healthcare and pharmaceuticalsdistribution of training materials in connection therewith
Classe 42
Scientific and technological servicesresearch and design in the field of software for managing healthcare data; analysis of technical data by computersbeing technical medical research in the field of healthcareprescription and related data being carried out using computers; pharmaceutical and biomedical research services; research in the field of pharmaceuticalbiologic therapeutic productsclinical trialspost-authorization medical research for the marketing of medicines and/or commercial post-launching of medicines and epidemiology; pharmaceutical research and development; providing scientific research information in the field of pharmaceuticalsbiomedicineclinical trialspost-authorization research for the marketing of medicines and/or commercial post-launching of medicines and epidemiology; providing temporary use of online non-downloadable computer software for allowing users to connect to databases containing pharmaceutical and medical information; providing temporary use of online non-downloadable computer software for management of medical practices and research in connection with or related to pharmaceutical commercialization; providing temporary use of online non-downloadable computer search engine software for obtaining and providing updated scientificmedical and clinical informationfor obtaining and providing news of general interest; providing temporary use of online non-downloadable computer software for accessing data and information related to healthcare services and patient medical informationfor controlling and managing data and information related to healthcare services and patient medical information
Classe 44
Providing health and medical information to potential customers of pharmaceutical products; providing internet-based healthcare information in support of potential commercialization of pharmaceutical products for the treatment of diseasesdisorders or conditions; providing health and medical information relating to the diagnosticprophylactic and therapeutic properties of pharmaceutical and biologic products for the prevention and treatment of diseasesdisorders and conditions; medical servicesproviding medical services and consultation related to pharmaceutical products or disease awareness over the telephone and via the Internet through the use of personal computerssmartphonestabletsmobile and wireless devicesother telecommunication devices; pharmaceutical advice; medical and pharmaceutical consultation related to pharmaceutical products or disease awareness; medical assistance services in the nature of the provision of medical informationinformation related to pharmaceutical products or disease awareness provided to medical professionals and potential patients from remote locations via the Internet and global computer networks through the use of a data storage and retrieval system
Publicações
Histórico de despachos e eventos da marca no USPTO.
31 publicações encontradas
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
28/11/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/11/2020
FIMP
FINAL DISPOSITION PROCESSED
06/11/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
14/10/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
14/07/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
28/04/2020
PUBO
PUBLISHED FOR OPPOSITION
28/04/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/04/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
25/03/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/03/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/03/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/03/2020
ALIE
ASSIGNED TO LIE
11/03/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/03/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
13/12/2019
ATRV
ATTORNEY REVIEW COMPLETED
06/11/2019
CREV
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
01/11/2019
RFNT
REFUSAL PROCESSED BY IB
20/09/2019
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
19/09/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/09/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/09/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/09/2019
RFRR
REFUSAL PROCESSED BY MPU
05/09/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
22/08/2019
CNRT
NON-FINAL ACTION WRITTEN
21/08/2019
MAFR
APPLICATION FILING RECEIPT MAILED
20/08/2019
DOCK
ASSIGNED TO EXAMINER
16/08/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
16/08/2019
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
31/07/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
18/07/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ALYVANT ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.